| Ranbaxy Laboratories (BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028) |
 |
501.60  -4.05 (-0.8%) |
| BSE : Aug 21, 10:30 |
|
| 501.05 -4.20 (-0.83%) |
| NSE : Aug 21, 10:38 |
|
| Open |
506.00 |
Vol |
42,347 |
| Prev. Close |
505.65 |
|
|
|
Intraday |
52 Week |
|
| Highs |
509.00 |
613.70 |
|
| Lows |
501.55 |
299.90 |
|
|
| Open |
512.00 |
Vol |
149,915 |
| Prev. Close |
505.25 |
|
|
|
Intraday |
52 Week |
|
| Highs |
512.00 |
660.00 |
|
| Lows |
500.10 |
297.05 |
|
|
|
BID |
OFFER |
| Price |
501.55 |
501.60 |
| Quantity |
10.00 |
40.00 |
|
|
BID |
OFFER |
| Price |
501.10 |
501.25 |
| Quantity |
10.00 |
497.00 |
|
| Mkt Cap |
18,721.61 |
| |
* P/E |
54.46 |
| |
Div |
170.00 |
| |
* EPS (TTM) |
9.21 |
| |
B/V: |
67.98 |
| Mkt Lot |
1.00 |
| |
FV |
5.00 |
| |
* EPS: As per stand alone adjusted profit after extra-ordinary items |
|
| Historic Prices & Returns of Ranbaxy Labs |
Compare Price Performance With Peers |
| Price |
1 week |
2 week |
1 month |
3 month |
6 month |
9 month |
1 year |
| BSE |
/ |
NSE |
| 499.05 |
516.05 |
458.20 |
510.90 |
412.20 |
413.85 |
364.90 |
| 0.51% |
-2.8% |
9.47% |
-1.82% |
21.69% |
21.2% |
37.46% |
| 499.30 |
516.75 |
458.35 |
511.10 |
412.90 |
414.20 |
364.95 |
| 0.38% |
-3.01% |
9.35% |
-1.94% |
21.39% |
21% |
37.33% |
|
Gain/Loss |
|
|
|
| This page Auto Refreshes every 5 minutes |
|
|
|
| |
|
|
|
|
|
| BSE/NSE Notices - Ranbaxy Labs |
| ICICI Securities Limited has informed the Exchange regarding the Public Announcement published on June 16, 2008 ('PA') published in the newspaper. As |
| |
| more... |
| |
|
|
|
| Financials of Ranbaxy Labs |
Quarterly |
Annual
|
| Income Statement |
(Jun '08) |
(Dec '07) |
| Net Sales |
1216.92 |
4026.60 |
| Other Income |
107.48 |
439.70 |
| PBDIT |
80.09 |
986.57 |
| Net Profit |
23.73 |
617.72 |
|
|
|
| Balance Sheet |
| Total Share Capital |
186.54 |
| Net Worth |
2538.40 |
| Total Debt |
3503.03 |
| Net Block |
1469.52 |
| Investments |
3237.55 |
| Net Current Assets |
1006.93 |
| Total Assets |
6041.42 |
|
|
|
|
|
|
|
|
|
| Company Facts - Ranbaxy Labs |
|
|
|
| Registrars |
Alankit Assignment Ltd.
2E/8, Blazeflash House,
R T A Division, 1st Floor
Jhandewalan Extension,
|
| Tel : 51540060, 51540061, 51540062, 51540063 |
| Fax : 51540064 |
| Email : nahar@alankit.com |
Website :
|
|
|
|
|
|
| Management - Ranbaxy Labs |
| |
| Harpal Singh Non Executive Chairman |
| Vivek Bharat Ram Director |
| Gurcharan Das Director |
| Sunil Godhwani Director |
| P S Joshi Director |
| Nimesh N Kampani Director |
| V K Kaul Director |
| Vivek Mehra Director |
| Ravi Mehrotra Director |
| Shivinder Mohan Singh Director |
| Surendra Daulet-Singh Director |
| Brian W Tempest Non Executive Director |
| Malvinder Mohan Singh Managing Director & CEO |
| Atul Sobti Whole Time Director & COO |
| Ramesh L Adige Whole Time Director |
| |
|
|
Online
